Log in  First Connection?

MelanomaArchives

Diagnostic value of 18F-FDG PET/CT in the follow-up of metastatic uveal melanoma
Melanoma
 4 min.

 Published on 27/10/2025 |  Original article (Full-text)  | Ma Huan et al. | Cancer imaging 2025; 25(1): 120

Uveal melanoma (UM) is a rare ocular tumor and is considered the most common primary malignant tumor in the adult eye [1]. In the China, the annual incidence rate is about 0.5 per million, accounting for 5% of all melanoma. In 90% of cases, it originates from the choroid, 7% from the ciliary body, and...

Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy – a pilot study
Melanoma
 7 min.

 Published on 20/10/2025 |  Original article (Full-text)  | Pöschmann Lea et al. | BMC Cancer 2025; 25(1): 1597

Melanoma, also known as malignant melanoma, is an aggressive tumour of the skin [1]. Since the introduction of immune checkpoint inhibitor (ICI) therapy for the advanced stages, there was an important change in treatment. The mechanism of action of ICI involves the modulation of T-cell, antigen-presenting...

Is the threat of malignant melanoma in the UK still increasing? A comprehensive analysis of 30 years of historical data and Bayesian age-period-cohort model projections for 2030.
Melanoma
 1 min.

 Published on 13/10/2025 |  Original article (Full-text)  | Chen, Haoa et al. | European Journal of Cancer Prevention. Volume 34(6).

Malignant melanoma, a highly aggressive skin cancer, though less common, significantly contributes to cancer-related mortality. In the UK, it is of growing concern with an aging population, making it crucial to analyze historical trends and forecast future burdens. We used Joinpoint regression and age-period-cohort...

Is there a role of surgical resection for uveal malignant melanoma liver metastases: report of two cases
Melanoma
 2 min.

 Published on 06/10/2025 |  Original article (Full-text)  | Oğuzhan Şal   et al. | Egyptian Liver Journal 2025; 15(1): 1-4

Ocular malignant melanoma (OMM) is a rare, aggressive eye cancer originating from melanocytes in the uveal tract. Despite treatments like enucleation and radiotherapy, OMM often metastasizes, primarily to the liver, significantly reducing the 5-year survival rate to about 15% for patients with liver...